Literature DB >> 23268329

High grade prostate intraepithelial neoplasia (PIN) is a PSA-independent risk factor for prostate cancer in African American men: results from a pilot study.

Ganna Chornokur1, Gang Han, Richard Tanner, Hui-Yi Lin, B Lee Green, Julio Pow-Sang, Catherine M Phelan.   

Abstract

African American men (AAM) demonstrate increased prostate cancer incidence and mortality rates. We investigated known prostate cancer risk factors in AAM. Prostate specific antigen (PSA) and diagnosis of high grade prostatic intraepithelial neoplasia (PIN) were significant prostate cancer predictors. However, even including AAM with low PSA (<4ng/ml), those with PIN had significantly elevated risk, compared to men without PIN (83.3% vs. 6.9%, p<0.0001). In AAM diagnosed with PIN, PSA level was no longer significant (83.3% vs. 92.3%, p=0.593 respectively). Our results suggest that a history of PIN is highly predictive of prostate cancer in AAM, and help provide PSA-independent venues for screening.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23268329      PMCID: PMC3603576          DOI: 10.1016/j.canlet.2012.12.014

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.

Authors:  Isaac J Powell; Cathryn H Bock; Julie J Ruterbusch; Wael Sakr
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

Review 2.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

Review 3.  A comparison of goodness-of-fit tests for the logistic regression model.

Authors:  D W Hosmer; T Hosmer; S Le Cessie; S Lemeshow
Journal:  Stat Med       Date:  1997-05-15       Impact factor: 2.373

4.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

5.  Trends in PSA, age and prostate cancer detection among black and white men from 1990-2006 at a tertiary care center.

Authors:  Jeannette M Potts; Megan Lutz; Esteban Walker; Charles Modlin; Eric Klein
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

6.  Prostatic intraepithelial neoplasia: A marker for high-risk groups and a potential target for chemoprevention.

Authors:  W A Sakr
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

Review 7.  Screening for prostate cancer: an updated Cochrane systematic review.

Authors:  Dragan Ilic; Denise O'Connor; Sally Green; Timothy J Wilt
Journal:  BJU Int       Date:  2011-03       Impact factor: 5.588

8.  Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race.

Authors:  J E Fowler; S A Bigler; C Lynch; S S Wilson; P B Farabaugh
Journal:  Cancer       Date:  2001-04-01       Impact factor: 6.860

9.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

10.  Contemporary risk profile of prostate cancer in the United States.

Authors:  Yu-Hsuan Shao; Kitaw Demissie; Weichung Shih; Amit R Mehta; Mark N Stein; Calpurnyia B Roberts; Robert S Dipaola; Grace L Lu-Yao
Journal:  J Natl Cancer Inst       Date:  2009-08-27       Impact factor: 13.506

View more
  3 in total

1.  Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer.

Authors:  Benjamin A Rybicki; Sudha M Sadasivan; Yalei Chen; Ian Loveless; Nilesh S Gupta; Dhananjay A Chitale; Sean R Williamson; Andrew G Rundle; Deliang L Tang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-05-04       Impact factor: 4.090

2.  Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer.

Authors:  Nagi B Kumar; Roshni Patel; Julio Pow-Sang; Philippe E Spiess; Raoul Salup; Christopher R Williams; Michael J Schell
Journal:  Oncotarget       Date:  2017-06-29

3.  Haplotypes of single cancer driver genes and their local ancestry in a highly admixed long-lived population of Northeast Brazil.

Authors:  Steffany Larissa Galdino Galisa; Priscila Lima Jacob; Allysson Allan de Farias; Renan Barbosa Lemes; Leandro Ucela Alves; Júlia Cristina Leite Nóbrega; Mayana Zatz; Silvana Santos; Mathias Weller
Journal:  Genet Mol Biol       Date:  2022-02-02       Impact factor: 1.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.